Cargando…
Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak
OBJECTIVES: Reduced plasma vitamin C concentrations in chronic diseases may result from abnormal urinary excretion of vitamin C excretion: a renal leak. We hypothesized that vitamin C renal leak may be the consequence of disease-mediated dysregulation affecting the renal tubules, resulting in aberra...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194231/ http://dx.doi.org/10.1093/cdn/nzac074.009 |
_version_ | 1784726673755734016 |
---|---|
author | Ebenuwa, Ifechukwude Violet, Pierre-Christian Padayatty, Sebastian Tu, Hongbin Wang, Yaohui Eck, Peter Wilkins, Kenneth Moore, David Schiffmann, Raphael Levine, Mark |
author_facet | Ebenuwa, Ifechukwude Violet, Pierre-Christian Padayatty, Sebastian Tu, Hongbin Wang, Yaohui Eck, Peter Wilkins, Kenneth Moore, David Schiffmann, Raphael Levine, Mark |
author_sort | Ebenuwa, Ifechukwude |
collection | PubMed |
description | OBJECTIVES: Reduced plasma vitamin C concentrations in chronic diseases may result from abnormal urinary excretion of vitamin C excretion: a renal leak. We hypothesized that vitamin C renal leak may be the consequence of disease-mediated dysregulation affecting the renal tubules, resulting in aberrant vitamin C renal reabsorption and increased urinary loss. The study objective was to investigate the prevalence, clinical characteristics, and genomic associations of vitamin C renal leak in Fabry disease, an X-linked lysosomal storage disease associated with renal tubular dysfunction and low plasma vitamin C concentration. METHODS: This was a non-randomized cross-sectional cohort study of males with Fabry disease (n = 34) and healthy male controls (n = 33). To determine primary outcome of vitamin C renal leak, matched urine and fasting plasma vitamin C measurements were obtained following an overnight fast. Based on data from healthy men, vitamin C renal leak was defined as presence of urinary vitamin C at plasma concentrations below 38 µM. Exploratory outcomes assessed the association between renal leak and clinical parameters; and genomic associations with renal leak using single nucleotide polymorphisms (SNPs) in the vitamin C transporter SLC23A1. Proof-of-concept studies were conducted using two mouse models. RESULTS: Compared with healthy men, Fabry cohort had 16-fold higher odds of renal leak (6% vs 52%: OR16, P < 0.001). Renal leak was associated with higher protein creatinine ratio (p = 0.01), lower hemoglobin (p = 0.002) and hematocrit (p = 0.008). Renal leak, but not plasma vitamin C, was associated with a non-synonymous single nucleotide polymorphism in vitamin C transporter SLC23A1 (p = 0.01 and p = 0.47 respectively). Using two mouse models, we recapitulated the relationships between renal leak, dysregulated vitamin C renal reabsorption and low plasma vitamin C concentrations. CONCLUSIONS: Increased prevalence of vitamin C renal leak in Fabry disease may result from dysregulated vitamin C renal physiology, with significant clinical and genomic associations. Renal leak may be more sensitive than plasma vitamin C in evaluating genomic associations in small cohorts. FUNDING SOURCES: Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20,892–1372. |
format | Online Article Text |
id | pubmed-9194231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91942312022-06-14 Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak Ebenuwa, Ifechukwude Violet, Pierre-Christian Padayatty, Sebastian Tu, Hongbin Wang, Yaohui Eck, Peter Wilkins, Kenneth Moore, David Schiffmann, Raphael Levine, Mark Curr Dev Nutr Vitamins and Minerals OBJECTIVES: Reduced plasma vitamin C concentrations in chronic diseases may result from abnormal urinary excretion of vitamin C excretion: a renal leak. We hypothesized that vitamin C renal leak may be the consequence of disease-mediated dysregulation affecting the renal tubules, resulting in aberrant vitamin C renal reabsorption and increased urinary loss. The study objective was to investigate the prevalence, clinical characteristics, and genomic associations of vitamin C renal leak in Fabry disease, an X-linked lysosomal storage disease associated with renal tubular dysfunction and low plasma vitamin C concentration. METHODS: This was a non-randomized cross-sectional cohort study of males with Fabry disease (n = 34) and healthy male controls (n = 33). To determine primary outcome of vitamin C renal leak, matched urine and fasting plasma vitamin C measurements were obtained following an overnight fast. Based on data from healthy men, vitamin C renal leak was defined as presence of urinary vitamin C at plasma concentrations below 38 µM. Exploratory outcomes assessed the association between renal leak and clinical parameters; and genomic associations with renal leak using single nucleotide polymorphisms (SNPs) in the vitamin C transporter SLC23A1. Proof-of-concept studies were conducted using two mouse models. RESULTS: Compared with healthy men, Fabry cohort had 16-fold higher odds of renal leak (6% vs 52%: OR16, P < 0.001). Renal leak was associated with higher protein creatinine ratio (p = 0.01), lower hemoglobin (p = 0.002) and hematocrit (p = 0.008). Renal leak, but not plasma vitamin C, was associated with a non-synonymous single nucleotide polymorphism in vitamin C transporter SLC23A1 (p = 0.01 and p = 0.47 respectively). Using two mouse models, we recapitulated the relationships between renal leak, dysregulated vitamin C renal reabsorption and low plasma vitamin C concentrations. CONCLUSIONS: Increased prevalence of vitamin C renal leak in Fabry disease may result from dysregulated vitamin C renal physiology, with significant clinical and genomic associations. Renal leak may be more sensitive than plasma vitamin C in evaluating genomic associations in small cohorts. FUNDING SOURCES: Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20,892–1372. Oxford University Press 2022-06-14 /pmc/articles/PMC9194231/ http://dx.doi.org/10.1093/cdn/nzac074.009 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Vitamins and Minerals Ebenuwa, Ifechukwude Violet, Pierre-Christian Padayatty, Sebastian Tu, Hongbin Wang, Yaohui Eck, Peter Wilkins, Kenneth Moore, David Schiffmann, Raphael Levine, Mark Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title | Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title_full | Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title_fullStr | Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title_full_unstemmed | Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title_short | Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Factors of Vitamin C Renal Leak |
title_sort | vitamin c urinary loss in fabry disease: clinical and genomic factors of vitamin c renal leak |
topic | Vitamins and Minerals |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194231/ http://dx.doi.org/10.1093/cdn/nzac074.009 |
work_keys_str_mv | AT ebenuwaifechukwude vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT violetpierrechristian vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT padayattysebastian vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT tuhongbin vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT wangyaohui vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT eckpeter vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT wilkinskenneth vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT mooredavid vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT schiffmannraphael vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak AT levinemark vitamincurinarylossinfabrydiseaseclinicalandgenomicfactorsofvitamincrenalleak |